This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Medicaid Drug Rebate Program (MDRP) Summit 2024
September 23-25, 2024
Delivered as a Hybrid EventChicago Marriott Downtown Magnificent Mile, Chicago, IL

Christopher Schott
Partner at Latham & Watkins
Speaker

Profile

Christopher H. Schott primarily advises on price reporting and other compliance obligations related to the Medicaid, Medicare, and 340B drug pricing programs. He combines extensive regulatory insight with deep industry knowledge to support pharmaceutical clients at all stages of the market access and product life cycle. In addition to advising on methodologies and reasonable assumptions that support the periodic certification and submission of pricing data, Chris also helps pharmaceutical manufacturers proactively engage with federal regulators through in-person advocacy. He also frequently advises drug manufacturers seeking guidance from regulators regarding specific issues or commercial proposals.

Agenda Sessions

  • HRSA 340B Integrity Initiatives – Manufacturer and Covered Entity Audits

    2:15pm
  • Ask the Attorney's: What Keeps Them Up at Night?

    12:30pm